James Cassidy Selected Research

James Cassidy Research Topics

Disease

14	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 03/2002
14	Neoplasms (Cancer) 01/2023 - 11/2002
4	Neutropenia 05/2013 - 02/2004
2	Breast Neoplasms (Breast Cancer) 11/2013 - 06/2009
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2013 - 05/2013
2	Colonic Neoplasms (Colon Cancer) 09/2013 - 01/2012
2	Lymphatic Metastasis 11/2002 - 03/2002
1	Testicular Neoplasms (Testicular Cancer) 11/2013
1	Hemorrhage 05/2011
1	Thromboembolism 05/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2010
1	Breast Cancer 3 06/2009
1	Ovarian Epithelial Carcinoma 01/2006
1	Ovarian Neoplasms (Ovarian Cancer) 01/2006
1	Alcoholism (Alcohol Abuse) 04/2003
1	Rectal Neoplasms (Rectal Cancer) 11/2002

Drug/Important Bio-Agent (IBA)

10	Fluorouracil (Carac)FDA LinkGeneric 05/2013 - 03/2002
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 05/2008
3	NF-kappa B (NF-kB)IBA 05/2010 - 04/2003
2	Leucovorin (Folinic Acid)FDA Link 05/2013 - 11/2010
2	Bevacizumab (Avastin)FDA Link 05/2011 - 05/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2008 - 11/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2006 - 11/2005
2	Thymidylate SynthaseIBA 08/2005 - 03/2002
2	Proteins (Proteins, Gene)FDA Link 11/2002 - 03/2002
1	figitumumabIBA 04/2014
1	Sodium Glutamate (Accent)IBA 09/2013
1	Sorafenib (BAY 43-9006)FDA Link 05/2013
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2012
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2012
1	olaparibIBA 08/2012
1	Topotecan (Hycamtin)FDA LinkGeneric 08/2012
1	vinyltriethoxysilane (VTES)IBA 05/2011
1	AnticoagulantsIBA 05/2011
1	ErbB Receptors (EGF Receptor)IBA 11/2010
1	Panitumumab (Vectibix)FDA Link 11/2010
1	Monoclonal AntibodiesIBA 11/2010
1	PowdersIBA 10/2010
1	Insulin (Novolin)FDA Link 10/2010
1	Glucose (Dextrose)FDA LinkGeneric 10/2010
1	triptolideIBA 05/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2010
1	AnthracyclinesIBA 06/2009
1	PolymersIBA 06/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2009
1	N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugateIBA 06/2009
1	SolutionsIBA 10/2008
1	NucleotidesIBA 01/2008
1	Propidium (Propidium Iodide)IBA 01/2008
1	Bromodeoxyuridine (BrdU)IBA 01/2008
1	XELOXIBA 05/2007
1	UridineIBA 05/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2006
1	Cisplatin (Platino)FDA LinkGeneric 01/2006
1	((S)- 2- (5- (1,2- dihydro- 3- methyl- 1- oxobenzo(f)- quinazoline- 9- yl)methyl)amino- 1- oxo- 2- isoindolynyl)- glutaric acidIBA 08/2005
1	BBR 3464 (BBR3464)IBA 02/2004
1	Platinum Compounds (Compounds, Platinum)IBA 02/2004
1	Disulfiram (Antabuse)FDA Link 04/2003
1	cerivastatin (Kazak)FDA Link 11/2002
1	Antineoplastic Agents (Antineoplastics)IBA 11/2002
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2002
1	trioctyl phosphine oxide (TOPO)IBA 11/2002
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 11/2002

Therapy/Procedure

10	Therapeutics 04/2014 - 02/2004
6	Drug Therapy (Chemotherapy) 11/2013 - 03/2002
1	Adjuvant Chemotherapy 01/2023